Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. 

Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

Joseph D. Feuerstein, MD

Beth Israel Deaconess Medical Center

Center for Inflammatory Bowel Disease

Harvard Medical School

Boston, MA

USA

Adam S. Cheifetz, MD

Beth Israel Deaconess Medical Center

Center for Inflammatory Bowel Disease

Harvard Medical School

Boston, MA

USA